Table 1.
Reported year | Population | The number of participants | Gene region |
---|---|---|---|
2017 | European ancestries | 2134 GCA patients 9125 controls |
HLA-DRA/HLA-DRB1, PLG, P4HA2 |
2018 | Japan | 415 TAK patients 2170 controls |
HLA-B, FCGR3A, IL12B, DUSP22, PTK2B, KLHL33, LILRA3, chr21q22 |
2015 | Turkey and North America | 693 TAK patients 1536 controls |
HLA-B/MICA, IL6, RPS9/LILRB3, chr21q22 |